뉴스
-
Samsung Bio·VUNO Fall on Rights Offerings…SHINPOONG·CHO-A↑[K-Bio Pulse]
On Aug. 28, major pharmaceutical and biotech companies saw mixed stock performances as investors responded
www.edaily.co.kr · 2026.08.29
-
Market Fluctuates, Daehwa Pharm, LabGenomics, and NeoImmuneTech Rise[K-Bio Pulse]
On the 7th, amid mixed trading in the South Korean stock market, pharmaceutical and biotech companies
www.edaily.co.kr · 2026.08.10
-
FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls...
On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed following a 5-for-1 reverse stock split...
www.edaily.co.kr · 2026.08.11
-
Lemon Healthcare Rebounds to Limit-Up on Second Trading Day; D&D Pharmatech, PharmaResearch Also ...
South Korea's pharmaceutical and biotech sector posted broad gains on Tuesday despite heightened market volatility that triggered a sell-side sidecar on the benchmark stock market early in the sessio...
www.edaily.co.kr · 2026.07.08
-
Mixed Market, Solid Footing: Psomagen and Jetema Stand Out [K-Bio Pulse]
While the domestic stock market has recently remained mixed and struggled to find a clear direction, the pharmaceutical and biotech sectors have carved out an upward trajectory.
www.edaily.co.kr · 2026.07.02
